General form of registration statement for all companies including face-amount certificate companies

Convertible Debt - Related Party (Detail Textuals 1)

v3.19.1
Convertible Debt - Related Party (Detail Textuals 1)
1 Months Ended 3 Months Ended 12 Months Ended
Jan. 19, 2019
$ / shares
shares
Jan. 19, 2018
$ / shares
shares
Dec. 28, 2017
USD ($)
Day
$ / shares
Mar. 31, 2018
USD ($)
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Mar. 31, 2019
Short-term Debt [Line Items]              
Aggregate gross proceeds         $ 900,000    
Proceeds from convertible debt issuance       $ 400,000 400,000 $ 500,000  
Convertible debt           $ 235,000  
Loss on extinguishment of debt       $ (590,392) $ (590,392)    
Emerald Health Sciences Inc              
Short-term Debt [Line Items]              
Initial conversion price | $ / shares   $ 0.10          
Number of notes converted into common stock | shares   9,000,000          
Effective interest rate       13.94% 13.94% 13.94%  
Emerald Health Sciences Inc | Subsequent Event              
Short-term Debt [Line Items]              
Initial conversion price | $ / shares $ 0.10            
Number of notes converted into common stock | shares 9,000,000            
Multi-Draw Credit Agreement              
Short-term Debt [Line Items]              
Effective interest rate             9.89%
Bridge Loan | Secured Promissory Note and Security Agreement | Emerald Health Sciences Inc              
Short-term Debt [Line Items]              
Aggregate gross proceeds     $ 900,000        
Bridge loan interest rate     12.00%        
Initial conversion price | $ / shares   $ 0.10 $ 0.10        
Proceeds from convertible debt issuance     $ 500,000        
Funding of remaining bridge loan     400,000        
Convertible debt     $ 265,000        
Number of trading days as of financing close date | Day     1        
Additional conversion liability     $ 360,000